GPR39 and breast carcinoma: We also compared proliferation rates of ZnR/GPR39 expressing MDA-MB-453 and BT20 breast cancer cells following daily treatment with Zn2+ (200 μM, 2 min) or EDTA (100 μM, 2 min).